# Perampanel

## Fycompa 2mg

| TAH Drug Code      | [OFYC](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OFYC)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of partial epileptic seizures with or without subsequent generalized seizures in patients over 4 years old. Adjuvant therapy for primary generalized tonic-clonic epileptic seizures in patients over 7 years old.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Dosing             | For mono/adjuvant treatment of Local epilepsy : Adult & adolescent(A40>12 years) Initially 2 mg daily， may be increased by 2-mg increments to a maintenance dose of 4-8 mg daily. Then， further increase by 2-mg increments to 12 mg daily. Child (4-11years) (>=30kg):Initially 2 mg daily， may be increased by 2-mg increments to a maintenance dose of 4-I418 mg daily. Then， further increase by 2-mg increments to 12 mg daily. Child (4-11years) (20-30kg):Initially 1mg daily， may be increased by 1-mg increments to a maintenance dose of 4-6mg daily. Then， further increase by 1-mg increments to 8mg daily. Child (J404-11years) (<20kg):Initially 1mg daily， may be increased by 1-mg increments to a maintenance dose of 2-4mg daily. Then， further increase by 0.5-mg increments to 6mg daily. For adjuvant treatment of Primary generalized tonic-clonic seizures : Adult & adolescent(>12 years) Initially 2 mg daily， may be increased by 2-mg increments to a maintenance dose of 8mg daily. Then， further increase by 2-mg increments to 12 mg daily. Child (7-11years) (>=30kg):Initially 2 mg daily， may be increased by 2-mg increments to a maintenance dose of 4-8 mg daily. Then， further increase by 2-mg increments to 12 mg daily. Child (7-11years) (20-30kg):Initially 1mg daily， may be increased by 1-mg increments to a maintenance dose of 4-6mg daily. Then， further increase by 1-mg increments to 8mg daily. Child (7-11years) (<20kg):Initially 1mg daily， may be increased by 1-mg increments to a maintenance dose of 2-4mg daily. Then， further increase by 0.5-mg increments to 6mg daily. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Contraindications  | Hypersensitivity to any component of the formulation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Adverse Effects    | Dizziness， somnolence. Decreased/increased appetite; aggression， anger， anxiety， confusional state; ataxia， dysarthria， balance disorder， irritability; diplopia， blurred vision; vertigo; nausea; back pain; gait disturbance， fatigue; increased wt; fall.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| More Info          | [UpToDate](https://www.uptodate.com/contents/perampanel-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

